Charlie Hospital Semarang Tbk. vs Bakrie Sumatera Plantations Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp430 (market cap 1.11T, 25.61M 24h volume), while Bakrie Sumatera Plantations Tbk. trades at Rp206 (market cap 495.03B, 8.12M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 2.2× Bakrie Sumatera Plantations Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (25.61M versus 8.12M). Which is the better fit depends on your goals.
| RSCH | UNSP | |
|---|---|---|
Market Cap | 1.11T | 495.03B |
Volume | 25.61M | 8.12M |
Lot | 256.07K | 81.22K |
Turnover | 10.76B | — |
Average Price | 420.16 | — |
Value | 10.76B | — |
Indicative Equilibrium Price | 430 | — |
Indicative Equilibrium Volume | 1.46K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →PT Bakrie Sumatra Plantation Tbk (the Company) was established in the Republic of Indonesia in 1911 as a joint venture between the United States and Netherland Companies under the name of NV Hollandsch Amerikaanse Plantage Maatschappij. The Company status is Domestic Investment and has 8822 employees.
Read more on UNSP →